Tatke A, et al. In situ gel of triamcinolone acetonide-loaded solid lipid nanoparticles for improved topical ocular delivery: tear kinetics and ocular disposition studies. Nanomaterials. 2019;9(1):33–40.

Article  Google Scholar 

Lindholm JM, et al. Perioperative subconjunctival triamcinolone acetonide injection for prevention of inflammation and macular oedema after cataract surgery. Acta Ophthalmol. 2020;98(1):36–42.

Article  CAS  PubMed  Google Scholar 

Formica ML, et al. Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications. Int J Pharm. 2020;573:118795.

Article  CAS  PubMed  Google Scholar 

Maggio E, et al. Retrobulbar triamcinolone for inflammatory choroidal neovascularization in pregnancy. BMC Ophthalmol. 2020;20(1):1–7.

Article  Google Scholar 

Vettorazzi S, et al. A guide to changing paradigms of glucocorticoid receptor function—a model system for genome regulation and physiology. FEBS J. 2022;289(19):5718–43.

Article  CAS  PubMed  Google Scholar 

Iovino C, et al. Intravitreal dexamethasone implant as a sustained release drug delivery device for the treatment of ocular diseases: a comprehensive review of the literature. Pharmaceutics. 2020;12(8):703.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee DJ. Intraocular implants for the treatment of autoimmune uveitis. J Funct Biomater. 2015;6(3):650–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kang-Mieler JJ, et al. Advances in ocular drug delivery systems. Eye. 2020;34(8):1371–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Errera M-H, et al. A comparison of the dexamethasone implant (Ozurdex®) and inferior fornix-based sub-tenon triamcinolone acetonide for treatment of inflammatory ocular diseases. Ocul Immunol Inflamm. 2019;27(2):319–29.

Article  CAS  PubMed  Google Scholar 

Jaffe GJ. Fluocinolone acetonide sustained drug-delivery implant for posterior segment eye diseases, in Vitreoretinal surgical techniques. Routledge; 2019. pp. 608–13.

Pacella E, et al. Effects of repeated intravitreal injections of dexamethasone implants on intraocular pressure: a 4-year study. Clin Ophthalmol (Auckland NZ). 2020;14:3611.

Article  CAS  Google Scholar 

Smith SJ, Smith BD, Mohney BG. Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review. Br J Ophthalmol. 2014;98(3):292–7.

Article  PubMed  Google Scholar 

Saraiya NV, Goldstein DA. Dexamethasone for ocular inflammation. Expert Opin Pharmacother. 2011;12(7):1127–31.

Article  CAS  PubMed  Google Scholar 

Yeh S, et al. Suprachoroidal injection of triamcinolone acetonide, CLS-TA, for macular edema due to noninfectious uveitis: a randomized, phase 2 study (DOGWOOD). Retina. 2019;39(10):1880–8.

Article  CAS  PubMed  Google Scholar 

Gilger BC, et al. Treatment of acute posterior uveitis in a Porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles. Investig Ophthalmol Vis Sci. 2013;54(4):2483–92.

Article  CAS  Google Scholar 

Li J, et al. A more efficient ocular delivery system of triamcinolone acetonide as eye drop to the posterior segment of the eye. Drug Deliv. 2019;26(1):188–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruponen M, Urtti A. Undefined role of mucus as a barrier in ocular drug delivery. Eur J Pharm Biopharm. 2015;96:442–6.

Article  CAS  PubMed  Google Scholar 

Kumar A, et al. Mucoadhesive formulations: innovations, merits, drawbacks, and future outlook. Pharm Dev Technol. 2020;25(7):797–814.

Article  CAS  PubMed  Google Scholar 

Lai SK, Wang Y-Y, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 2009;61(2):158–71.

Article  CAS  PubMed  Google Scholar 

Ensign LM, et al. Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery. Adv Mater. 2012;24(28):3887–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rossi S, et al. Recent advances in the mucus-interacting approach for vaginal drug delivery: from mucoadhesive to mucus-penetrating nanoparticles. Expert Opin Drug Deliv. 2019;16(8):777–81.

Article  CAS  PubMed  Google Scholar 

Popov A. Mucus-penetrating particles and the role of ocular mucus as a barrier to micro- and microsuspensions. J Ocul Pharmacol Ther. 2020;36(6):366–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nafee N, et al. Mucus-penetrating solid lipid nanoparticles for the treatment of cystic fibrosis: proof of concept, challenges and pitfalls. Eur J Pharm Biopharm. 2018;124:125–37.

Article  CAS  PubMed  Google Scholar 

Popov A, et al. Mucus-penetrating nanoparticles made with mucoadhesive poly (vinyl alcohol). Nanomed Nanotechnol Biol Med. 2016;12(7):1863–71.

Article  CAS  Google Scholar 

Deshkar S, et al. Poloxamer modified Chitosan nanoparticles for vaginal delivery of acyclovir. Pharm Nanatechnol. 2021;9(2):141–56.

Article  CAS  Google Scholar 

Date AA, et al. Mucus-penetrating Budesonide microsuspension enema for local treatment of inflammatory bowel disease. Biomaterials. 2018;185:97–105.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patel HM, et al. Microsuspension technologies for delivery of poorly soluble Drugs-A review. Res J Pharm Technol. 2016;9(5):625–32.

Article  Google Scholar 

Nafee N, Schneider M. Towards a versatile technique for tracking nanoparticle-mucus interaction: a step on the road. Nanoscale imaging, sensing, and actuation for biomedical applications XI. International Society for Optics and Photonics; 2014.

Bujňáková Z, et al. Stability studies of As4S4 microsuspension prepared by wet milling in poloxamer 407. Int J Pharm. 2015;478(1):187–92.

Article  PubMed  Google Scholar 

Kuroiwa Y, et al. Nano-scale and molecular-level Understanding of wet-milled indomethacin/poloxamer 407 microsuspension with TEM, suspended-state NMR, and Raman measurements. Int J Pharm. 2018;537(1–2):30–9.

Article  CAS  PubMed  Google Scholar 

Ibrahim SS. The role of surface active agents in ophthalmic drug delivery: a comprehensive review. J Pharm Sci. 2019;108(6):1923–33.

Article  CAS  PubMed  Google Scholar 

Kumar A, et al. A review on mucoadhesive drug delivery systems. Research journal of pharmaceutical dosage forms and technology. 2019;11(4):280–7.

Article  Google Scholar 

Rhushikesh S, Suresh S. A review on mucoadhesive drug delivery system. Int J Res Anal Rev. 2020;7(1):793–808.

Google Scholar 

Burhan AM, et al. Posterior segment ophthalmic drug delivery: role of muco-adhesion with a special focus on chitosan. Pharmaceutics. 2021. https://doi.org/10.3390/pharmaceutics13101685.

Article  PubMed  PubMed Central  Google Scholar 

Nunes R, et al. Surface modification with polyethylene glycol enhances colorectal distribution and retention of nanoparticles. Eur J Pharm Biopharm. 2018;130:200–6.

Article  CAS  PubMed